Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European epidemiologic registry of cystic fibrosis

Pediatric Pulmonology

Volumn 32, Issue 5, 2001, Pages 343-350

  Koch, C ^a,f,g,h   Rainisio, M ^a   Madessani, U ^b   Harms, H K ^c   Hodson, M E ^d   Mastella, G ^e   McKenzie, S G ^f   Navarro, J ^g   Strandvik, B ^h  

^a University of Copenhagen   (Denmark)

^b Statistics for Research   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e Cystic Fibrosis Center   (Italy)

^f F HOFFMANN LA ROCHE LTD   (Switzerland)

^g Pediatric Sleep Disorders Center   (France)

^h QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Cystic fibrosis; Diabetes mellitus; Pulmonary function; Registry

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROPE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; NUTRITION; PREDICTION; PRIORITY JOURNAL; REGISTER; RESPIRATORY TRACT INFECTION; SURVIVAL;

ADOLESCENT; ADULT; BODY MASS INDEX; CHILD; CYSTIC FIBROSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FORCED EXPIRATORY VOLUME; HUMANS; VITAL CAPACITY;

EID: 0034759112     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.1142     Document Type: Article

References (27)

1. Determinants of mortality from cystic fibrosis in Canada, 1970-1989
2. Cystic fibrosis: Current survival and population estimates to the year 2000
3. Improved survival in the Danish center-treated cystic fibrosis patients: Results of aggressive treatment
4. The changing epidemiology of cystic fibrosis
5. Diabetes mellitus in Danish cystic fibrosis patients: Prevalence and late diabetic complications
6. Glucose tolerance in patients with cystic fibrosis: A five-year prospective study
7. Diabetes mellitus associated with cystic fibrosis
8. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis
9. International practice pattern by age and severity of lung disease in cystic fibrosis: Data from the Epidemiologic Registry of Cystic Fibrosis (ERCF)
10. European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations
11. Changes in the normal maximal expiratory flow-volume curve with growth and aging
12. Physical growth: National Center for Health Statistics percentiles
13. Pathogenesis of cystic fibrosis
14. CF-related diabetes: The ESCF experience
15. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto
16. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline
17. Other organ systems
18. Patterns of medical practice in cystic fibrosis: Part II. Use of therapies
19. Diabetic microangiopathy in patients with cystic fibrosis
20. Diabetes mellitus in cystic fibrosis: A review
21. The interaction of two diseases: Diabetes mellitus and cystic fibrosis
22. Proteolysis associated with insulin resistance in cystic fibrosis
23. Impaired insulin action in puberty. A contributing factor to poor glucemic control in adolescents with diabetes
24. Growth hormone improves weight velocity and height velocity in prepubertal children with cystic fibrosis
25. Anabolic effects of growth hormone treatment in young children with cystic fibrosis
26. Effects of growth hormone treatment in children with cystic fibrosis: The National Cooperative Growth Study experience